Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Crpc

PSA Drop Seen with New Prostate Cancer Drug

Half of a group of men with castration-resistant prostate cancer (CRPC) had biochemical responses to treatment with an investigational androgen receptor modulator, data from a preliminary clinical study showed.

During 12 weeks of treatment with galeterone, prostate-specific antigen (PSA) declined by at least 30% in 24 of 49 patients, 11 of whom had declines… PSA Drop Seen with New Prostate Cancer Drug   



Antifungal May Help in Prostate Cancer

Men with castration-resistant prostate cancer (CRPC) that was not mediated by androgen suppression experienced better outcomes when treated with an antifungal agent, according to a small clinical study reported here.

Men treated with the maximum recommended dose of itraconazole had a median progression-free survival (PFS) of 36 weeks, and 61% of the patients were… Antifungal May Help in Prostate Cancer   



Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded

A new statement by Janssen Research & Development, LLC informs that they have unblinded the Phase 3 study, COU-AA-302, which shows that Zytiga (abiraterone acetate), when taken alongside prednisone, is effective in treating mildly symptomatic or asymptomatic patients who are suffering from metastatic castration-resistant prostate cancer (CRPC) and have not gone through chemotherapy. … Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded   



For advanced prostate cancer, new drug slows disease

A new medication proved effective in slowing the spread of metastatic prostate cancer, while helping to maintain the quality of life, in patients with advanced disease. The phase 3 study was unblinded midway, allowing patients receiving the placebo to instead take the drug because of the favorable results.

The study is the first randomized… For advanced prostate cancer, new drug slows disease   



sexually transmitted infections1 - ccrcc1 - external sphincter dyssynergia1 - abbott diagnostics1 - kit kat1 - av fistula1 - stone recurrence1 - kidney care1 - gamete intrafallopian transfer1 - jasn8 - prostate-specific antigen test1 - buttocks1 - diagnostic tools1 - acupuncture1 - ureteropelvic stone1 - hyperlipidemia1 - dstyk1 - risk of cancer1 - glomerular filtration rate4 - prostate cancer imaging1 - uterine2 - prostate-specific antigen screening1 - intravenous pyelography5 - prostate removal surgery1 - urethral sphincter2 - hematuria8 - peritoneal dialysis3 - psa-test1 - renal colic3 - measuring psa1 -